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Abstract
Objective:  To  analyze  the  implementation  of  a  protocol  proposed  by  the  Brazilian  National
Health Surveillance  Agency  (Agência  Nacional  de  Vigilância  Sanitária  --  ANVISA)  to  improve
sepsis  diagnosis  in  very  low  birth  weight  newborns.
Methods:  This  was  a  prospective  study  that  evaluated  the  implementation  of  a  protocol  involv-
ing clinical  and  laboratory  criteria  (hematologic  scoring  system  of  Rodwell  and  C-reactive
protein serial  measurements),  recommended  by  ANVISA,  to  improve  the  diagnosis  of  neona-
tal  sepsis  in  very  low  birth  weight  newborns.  The  study  included  all  patients  who  were  born  and
remained  in  the  neonatal  intensive  care  unit  until  discharge  or  death,  and  excluded  those  with
congenital  diseases.  The  main  outcomes  measured  in  newborns  before  (2006-2007)  and  after
implementation  of  the  protocol  (2008)  were  the  rates  of  early  and  late-onset  sepsis,  use  of
antibiotics,  and  mortality.  Means  were  compared  by  Student’s  t-test  and  categorical  variables
were  compared  by  the  chi-squared  test;  the  signiﬁcance  level  for  all  tests  was  set  at  95%.
Results:  The  study  included  136  newborns  with  very  low  birth  weight.  There  was  no  difference
between groups  regarding  general  clinical  characteristics  in  the  studied  periods.  There  was,
however,  a  decrease  in  the  number  of  diagnoses  of  probable  early-onset  sepsis  (p  <  0.001),
use  of  antimicrobial  regimens  (p  <  0.001),  and  overall  mortality  and  infection-related  mortality
(p  =  0.009  and  p  =  0.049,  respectively).
Conclusion:  The  implementation  of  the  protocol  allowed  improvement  of  sepsis  diagnosis  by
reducing the  diagnosis  of  probable  early-onset  sepsis,  thus  promoting  efﬁcient  antimicrobial
use  in  this  population.
© 2013  Sociedade  Brasileira  de  Pediatria.  Published  by  Elsevier  Editora  Ltda.  
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PALAVRAS-CHAVE
Sepse  neonatal;
Recém-nascido  de
muito baixo  peso;
Diagnóstico
Aplicac¸ão  de  protocolo  proposto  pela  Agência  Nacional  de  Vigilância  Sanitária
(ANVISA)  para  uso  de  antibióticos  em  recém-nascidos  de  muito  baixo  peso
Resumo
Objetivo:  Analisar  a  aplicac¸ão  de  um  protocolo  proposto  pela  Agência  Nacional  de  Vigilância
Sanitária (ANVISA)  para  aprimorar  o  diagnóstico  de  sepse  em  recém-nascidos  de  muito  baixo
peso.
Métodos:  Estudo  prospectivo  que  avaliou  a  aplicac¸ão  de  protocolo  envolvendo  critérios  clínicos
e laboratoriais  (escore  hematológico  de  Rodwell  e  dosagem  seriada  da  proteína  C-reativa),
recomendado  pela  ANVISA,  para  aprimorar  o  diagnóstico  de  sepse  neonatal  em  recém-nascidos
de  muito  baixo  peso.  Participaram  do  estudo  todos  os  pacientes  que  nasceram  e  permaneceram
na  Unidade  Neonatal  até  a  alta  ou  óbito,  e  foram  excluídos  aqueles  com  doenc¸as  congênitas.
Os  principais  desfechos  analisados  entre  os  recém-nascidos  antes  da  aplicac¸ão  do  protocolo
(2006-2007)  e  após  a  aplicac¸ão  do  mesmo  (2008)  foram  as  taxas  de  sepses  precoce  e  tardia,  o
uso  de  antimicrobianos  e  a  mortalidade.  As  médias  foram  comparadas  por  meio  de  teste  t  e  as
variáveis  categóricas  pelo  teste  Qui-quadrado  (X2);  o  nível  de  signiﬁcância  para  todos  eles  foi
ﬁxado  em  95%.
Resultados:  Foram  incluídos  no  estudo  136  recém-nascidos  de  muito  baixo  peso.  Não  houve
diferenc¸a entre  os  grupos  em  relac¸ão  às  características  clínicas  gerais  nos  períodos  estudados.
Houve,  no  entanto,  reduc¸ão  na  quantidade  de  diagnóstico  de  sepse  precoce  provável  (p  <  0,001),
de  uso  de  esquemas  antimicrobianos  (p  <  0,001)  e  da  mortalidade  geral  e  associada  à  sepse
(p  =  0,009  e  p  =  0,049,  respectivamente).
Conclusão:  A  utilizac¸ão  do  protocolo  permitiu  aprimorar  o  diagnóstico  de  sepse,  reduzindo
aquele de  sepse  precoce  provável,  promovendo,  desta  forma,  o  uso  racional  de  antimicrobianos
na  populac¸ão  estudada.
© 2013  Sociedade  Brasileira  de  Pediatria.  Publicado  por  Elsevier  Editora  Ltda.  
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Este é um artigo Open Access sob a licença de CC BY-NC-NDIntroduction
In  spite  of  advances  in  obstetric  care  and  intrapartum
use of  antimicrobial  agents  for  streptococcal  infection  pro-
phylaxis, neonatal  sepsis  remains  an  important  cause  of
morbidity and  mortality  in  newborns  (NBs),  especially  in
those who  weigh  less  than  1,500  g.1--7 The  clinical  pic-
ture of  neonatal  sepsis  and  laboratory  diagnosis  are  usually
nonspeciﬁc.8,9 Blood  cultures,  which  are  considered  the
gold standard,  have  widely  variable  positive  results  and
may be  false  negative  in  20%  of  cases;  moreover,  their
results are  not  readily  available  to  deﬁne  the  therapeutic
conduct.10--13 Thus,  neonatologists  often  empirically  admin-
ister antibiotics  to  symptomatic  NBs  or  those  at  high  risk
of sepsis,  while  awaiting  culture  results;  even  when  cul-
tures are  negative,  they  tend  to  not  withdraw  the  use  of
antimicrobials.7
In  2008,  the  Brazilian  National  Health  Surveillance
Agency (Agência  Nacional  de  Vigilância  Sanitária  -  ANVISA)
submitted to  public  consultation  a  handbook  for  the  diagno-
sis of  healthcare-related  infections  (HCRI)  in  neonatology,14
which  established  the  diagnosis  of  primary  infection  of  the
bloodstream based  on  the  use  of  hematological  clinical
criteria (hematologic  scoring  system  of  Rodwell),  serial  mea-
surements of  C-reactive  protein  (CRP),  and  partial  results  of
blood cultures  collected  at  the  time  of  sepsis  diagnosis.15,16The  association  of  normal  leukocyte  count  with  serial  mea-
surements of  negative  CRP  may  help  to  rule  out  this  diagnosis
within one  to  three  days  of  clinical  evolution,  increasing  the
probability of  a  correct  diagnosis.7,15
t
g
h
cThis  study  aimed  to  analyze  the  impact  of  using  a  pro-
ocol recommended  by  ANVISA  to  improve  the  diagnosis  of
robable sepsis  in  NBs  with  very  low  weight.
ethods
his  prospective  study  was  conducted  to  analyze  the  imple-
entation of  a  protocol  for  the  diagnosis  of  neonatal  sepsis
ased on  clinical  and  laboratory  criteria,  in  NBs  with  birth
eight of  1,500  g  or  less  from  January,  2006  to  December,
008. The  period  of  protocol  implementation  (January-
ecember 2008)  was  termed  the  post-intervention  period;
he previous  period  was  termed  pre-intervention.  The  study
ncluded all  patients  who  were  born  and  remained  in  the
eonatal intensive  care  unit  (NICU)  until  discharge  or  death,
nd excluded  those  with  congenital  malformations  or  dis-
ases, those  transferred  from  other  health  services,  and
hose who  died  on  the  same  day  as  birth.
The  study  was  performed  in  the  NICU  of  Hospital
niversitário  Antônio  Pedro  of  the  Universidade  Federal  Flu-
inense (HUAP/UFF),  consisting  of  15  beds  with  a  mean  of
50 admissions/year.  The  hospital  has  a clinical  routine  that
onsists of  two  neonatologists  in  charge  of  medical  deci-
ions, including  the  use  of  antimicrobial  agents.  Protocol
mplementation was  supervised  daily  by  the  clinical  rou-
ine, and  the  team’s  adherence  was  considered  to  be  very
ood. During  the  study  period,  there  were  no  changes  in  the
ealth unit  staff  nor  additions  of  technological  features  that
ould differentiate  the  study  periods.  There  was  no  obstetric
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outine  for  group  B  streptococcus  infection  prophylaxis  nor
rophylaxis in  case  of  premature  rupture  of  membranes  and
reterm delivery  with  no  apparent  cause  and  treatment  of
horioamnionitis.
ntervention
ollection  of  complete  blood  count  (CBC),  CRP  levels,  blood
ulture, and  cerebrospinal  ﬂuid  at  the  time  of  the  suspected
epsis (before  the  antibiotic  therapy)  were  performed,  as
ell as  CBC  and  CRP  48  hours  after  the  start  of  antibiotic
herapy. The  normalization  of  the  clinical  picture,  nega-
ive blood  cultures,  negative  serum  CRP  measurements,
nd normal  hematological  parameters  48  hours  after  start
f antibiotic  therapy  ruled  out  the  diagnosis  of  sepsis,  and
he antibiotic  therapy  was  suspended.  NBs  were  classiﬁed
s: conﬁrmed  sepsis  (CS)  --  clinical  picture  compatible  with
epsis and  positive  culture;  probable  sepsis  (PS)  --  clini-
al picture  compatible  with  sepsis,  altered  WBC  and/or
RP results,  negative  cultures,  followed  by  treatment  with
ntibiotics for  at  least  seven  days;  non-infected  (NI)  --  ini-
ial clinical  suspicion  of  sepsis,  but  absence  of  clinical  course
onsistent with  infection,  normal  WBC  and  CRP  results,  and
egative cultures.
Maternal  variables  evaluated  were  type  of  delivery,  clin-
cal and  laboratory  signs  of  maternal  infection  (presence  of
ever and  antibiotic  use),  and  time  of  ruptured  membranes
t birth.  The  neonatal  data  were:  birth  weight,  gestational
ge, gender,  length  of  hospitalization,  severity  criterion
SNAPPE II),  and  mortality,  as  well  as  variables  related  to  the
ain neonatal  diseases  and  to  the  diagnosis  and  treatment
f neonatal  sepsis.
tatistical  analysis
he  comparison  of  the  data  collected  during  the  study
eriod was  described  based  on  measures  of  central  tendency
continuous variables:  mean,  standard  deviation,  median,
inimum and  maximum  values)  and  percentages  (categor-
cal variables).  The  means  of  continuous  variables  of  the
tudy groups  were  compared  by  Student’s  t-test  and,  when
ecessary, by  the  nonparametric  Mann-Whitney  test.  Cat-
gorical variables  were  compared  by  the  chi-squared  test
ith Fisher’s  correction,  when  necessary.  A  logistic  regres-
ion was  performed  to  assess  the  inﬂuence  of  protocol  use
n the  diagnosis  of  neonatal  sepsis  (conﬁrmed  and  proba-
le). The  signiﬁcance  level  for  all  tests  was  set  at  0.05;  a
5% conﬁdence  interval  was  calculated,  when  necessary.  The
tatistical Package  for  Social  Sciences  (SPSS)  release  16.0  for
indows was  used  in  all  statistical  analyses.
The  study  was  approved  by  the  Research  Ethics  Commit-
ee of  HUAP/UFF,  under  protocol  No.  CAAE:  0040.0.258.000-
0.
esultsuring  the  study  period,  172  NBs  with  birth  weight  <1,500  g
ere  admitted  to  the  NICU.  The  study  included  136  NBs
79.1%), and  excluded  36  (20.9%).  Among  the  excluded  NBs,
0 (55.6%)  were  transferred  to  or  from  other  services,  11
N
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30.6%)  had  malformations  and/or  congenital  infection,  and
ve (13.9%)  died  on  the  same  day  as  birth.  The  NBs  included
n the  study  were  divided  into  two  groups  for  comparison:
Bs admitted  in  the  pre-intervention  (n  =  91),  and  NBs  admit-
ed in  the  post-intervention  period  (n  =  45).  There  was  no
ifference between  groups  regarding  the  clinical  variables
tudied, except  for  the  time  of  amniotic  membrane  rupture
Table 1).
There was  no  difference  between  the  two  groups  in
elation to  the  diagnosis  of  CS;  however,  regarding  the
iagnosis of  PS,  there  was  a  signiﬁcant  reduction  in  the
ost-intervention period,  particularly  for  the  diagnosis  of
robable early-onset  sepsis  (Table  2).  The  number  of  pos-
tive blood  cultures  did  not  differ  between  periods  (10.8%
s. 16.3%,  between  the  pre-  and  post-intervention  periods,
espectively). Overall  mortality  and  infection-related  mor-
ality decreased  in  the  post-intervention  period.
There  was  a decrease  in  the  number  of  antimicrobial  regi-
ens used  (both  the  ﬁrst  and  third  regimens)  and  in  the
umber of  days  of  antibiotic  use.  However,  the  mean  length
f treatment  in  NBs  that  required  antimicrobial  treatment
as not  different  between  the  groups.  There  was  also  a
ecrease in  the  need  for  carbapenem  use  (Table  3).
After  using  binary  logistic  regression,  the  ‘‘Enter’’
ethod, and  probability  threshold  to  accept  0.05  variables,
aving as  the  dependent  variable  the  protocol  implementa-
ion period  it  was  observed  that  NBs  in  the  pre-intervention
eriod were  6.64  times  more  likely  to  have  a  diagnosis  of
eonatal sepsis  than  those  in  the  post-intervention  period
95% CI:  2.798  to  15.761,  p  <  0.001),  and  therefore  six  times
ore likely  to  receive  antibiotics  (Table  4).
It  is  noteworthy  that  the  sample  number  in  this  study  (136
Bs) was  determined  by  convenience,  i.e.,  it  was  according
o the  number  of  infants  born  during  the  study  period.  How-
ver, this  number  allowed  for  the  assessment  of  the  decrease
n the  incidence  of  sepsis  in  up  to  80%,  with  80%  power  (type
 error  of  20%),  and  a  signiﬁcance  level  of  5%.
iscussion
fter  implementing  the  ANVISA  manual  as  a  protocol  to
mprove the  diagnosis  of  neonatal  sepsis,  there  was  a
ecrease in  the  diagnosis  of  probable  early-onset  sepsis  and,
onsequently, a  decrease  in  the  use  of  antimicrobials,  espe-
ially of  the  ﬁrst  regimen  (ampicillin  +  gentamicin).  The
ecrease in  the  diagnosis  of  probable  early-onset  sepsis  and
herefore, in  the  need  to  treat  these  NBs  with  suspected
epsis, was  the  most  signiﬁcant  result  of  this  study.
The  difﬁculty  in  ruling  out  the  diagnosis  of  sepsis  in  NBs
as been  considerably  discussed,  especially  in  those  with
ery low  birth  weight,  due  to  lack  of  speciﬁcity  of  current
arameters for  this  diagnosis,  namely:  clinical  presentation,
resence of  risk  factors,  and  laboratory  results.7,15,16 These
actors lead  to  the  overuse  of  antibiotics  and  to  their  poten-
ial consequences,  such  as  toxicity  and  increased  bacterial
esistance.
Antibiotics are  the  most  often  prescribed  drugs  in  the
ICU, and  their  rational  use  is  crucial.  The  use  of  broad-
pectrum antimicrobials  for  a  prolonged  period  of  time  is
ssociated with  increased  risk  of  invasive  candidiasis,  necro-
izing enterocolitis  (NEC),  late-onset  sepsis,  and  increased
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Table  1  Comparison  of  clinical  characteristics  of  the  groups  of  newborns  studied  in  the  pre-  and  post-intervention  periods  --
Niterói,  RJ,  Brazil,  2006-2008.
Variable  Pre-intervention  period  (n  =  91)  Post-intervention  period  (n  =  45)  p-value
Mean  ±  SD  Median  (MV  and  mv)  Mean  ±  SD  Median  (MV  and  mv)
Birth  weight 1,112  ±  256 1,157 (540-1490) 1,160  ±  249  1,185  (570-1500)  0.214
Gestational  age  (weeks) 29  ±  2 30  (23-38) 30 ±  2 30  (24-36)  0.875
Days  in  NICU 43 ±  30 40 (1-210) 47 ±  34 38 (7-210) 0.407
Time of  amniotic  membrane
rupture (hours)
14 ±  34  0  (0-240)  56  ±  117  0  (0-480)  0.024
SNAPPE-II  value  20  ±  18  15  (0-79)  15  ±  12  10  (0-59)  0.061
n (%)  n  (%)  p-value
Male  gender  42  (46.2%)  26  (57.8%)  0.402
Patent  ductus  arteriosus  14  (15.4%)  11  (24.4%)  0.169
Pulmonary  bronchodysplasia 7  (7.7%) 2  (4.4%) 0.172
Necrotizing enterocolitis 14  (15.4%) 4  (8.9%) 0.220
Surgical delivery 61  (67.0%) 33  (73.3%) 0.293
Maternal fever 6  (6.6%) 3  (6.7%) 0.654
Maternal intrapartum  antibiotic  use 25 (27.5%) 17  (37.8%) 0.151
MV, maximum value; mv, minimum value; NICU, neonatal intensive care unit; SD, standard-deviation.
Table  2  Comparison  between  groups  in  the  pre-  and  post-intervention  periods  for  the  variables  related  to  the  diagnosis  of
neonatal  sepsis  and  mortality  --  Niterói,  RJ,  Brazil,  2006-2008.
Variable Pre-intervention
period  (n  =  91)  n  (%)
Post-intervention
period (n  =  45)  n  (%)
p-value
Probable  sepsis  79  (86.8%)  20  (44.4%)  <0.001
Conﬁrmed  sepsis  20  (22.0%)  10  (22.2%)  0.453
Probable  early-onset  sepsis  62  (68.1%)  16  (35.6%)  <0.001
Late-onset  sepsis  35  (38.5%)  14  (31.1%)  0.259
Presence  of  multi-resistant  agent  10  (11.0%)  2  (4.4%)  0.117
Overall  mortality  19  (20.9%)  2  (4.4%)  0.009
Infection-related  mortality  14  (15.4%)  2  (4.4%)  0.049
Table  3  Comparison  of  the  number  of  regimens  and  treatment  duration  in  groups  of  newborns  studied  --  Niterói,  RJ,  Brazil,
2006-2008.
Variables  Pre-intervention  period  (n  =  91)  Post-intervention  period  (n  =  45)  p-value
Mean  ±  SD  Median  (MV  and  mv)  Mean  ±  SD  Median  (MV  and  mv)
Number  of  antibiotic  regimens  1.6  ±  1.3  1.0  (0-7)  0.8  ±  0.8  1  (0-3)  0.001
Days  of  antibiotic  use  15.1  ±  12.6  11.5  (0-64)  8.4  ±  11  7.0  (0-48)  0.002
Time  of  treatment  with  antibiotics  18.2  ±  11.8  14  (7-64)  15  ±  11  10  (7-48)  0.229
n (%)  N  (%)  X2
First  antibiotic  regimen  83  (91.2%)  26  (57.8%)  0.001
Second  antibiotic  regimen  30  (33%)  9  (20%)  0.083
Third  antibiotic  regimen  20  (22%)  1  (2.2%)  0.001
Vancomycin  13  (14.3%)  3  (6.7%)  0.165
Carbapenem  17  (18.7%)  3  (6.7%)  0.049
First antibiotic regimen: ampicillin + gentamycin; Second antibiotic regimen: oxacillin + amikacin; Third antibiotic regimen:
cefepime + vancomycin.
MV, maximum value; mv, minimum value; SD, standard-deviation.
454  Pinto  MC  et  al.
Table  4  Binary  logistic  regression  -  dependent  variable:  protocol  implementation  period  --  Niterói,  RJ,  Brazil,  2006-2008.
Exp  B  95%CI  p-value
Min  Max
Sepsis  (probable  and  conﬁrmed)  6.64  2.79  15.76  <0.001
Total  death  5.67  1.25  25.56  0.024
Sepsis-related  death  4.82  0.59  39.36  0.141
Use  of  ﬁrst  antibiotic  regimen  7.58  2.97  19.33  <  0.001
Use  of  third  antibiotic  regimen  12.39  1.60  95.63  0.160
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1Use  of  carbapenem 3.21
acterial  resistance.17--22 In  this  NICU,  aminoglycosides  are
sed to  treat  both  early-onset  and  late-onset  sepsis.  Medi-
al literature  reports  that  adverse  events  in  the  short  and
ong-term, such  as  cochlear  and  vestibular  damage,  may
ccur with  the  use  of  aminoglycosides.  In  2010,  the  National
atient Safety  Agency  (NPSA)  reported  507  adverse  events
nvolving the  use  of  gentamicin  in  NBs  within  one  year.23
hus,  any  possibility  to  reduce  the  use  of  antibiotics  in  NBs,
 population  at  high  risk  for  neonatal  sepsis,  is  essential.
This  study,  however,  showed  no  decrease  in  the  diagnosis
f late-onset  sepsis,  as  this  diagnosis  is  based  on  altered
linical and  laboratory  tests,  leaving  no  doubts  regarding
reatment for  the  clinical  staff.
Blackburn  et  al.  questioned  the  safety  of  the  withdraw-
ng antibiotic  therapy  in  neonates  with  probable  early-onset
epsis after  36  hours  of  suspected  diagnosis,  considering  the
ow sensitivity  of  blood  cultures.  There  have  been  reports
f positive  blood  cultures  in  the  neonatal  period  in  NBs  with
uspected sepsis  of  12%  for  bacteria  or  fungi,  and  of  only  2%
n  the  ﬁrst  day  of  life.24 The  present  study  demonstrated  the
ffectiveness and  safety  of  withdrawing  the  antimicrobial
herapy based  on  the  protocol  proposed  by  ANVISA,  as  none
f the  NBs  evaluated  through  the  protocol  needed  to  return
o antibiotic  therapy  or  had  reported  clinical  worsening.
Even  though  the  time  of  prolonged  rupture  of  membranes
as four  times  higher  in  the  post-intervention  group,  the  use
f  the  protocol  decreased  the  need  for  antibiotic  use  in  this
opulation.
Mortality rates  (overall  and  infection-related)  decreased
n the  post-intervention  period.  There  was  no  difference  in
everity among  the  NBs  treated  in  the  periods  studied  nor
egarding the  presence  of  major  morbidities,  including  the
ate of  CS.  As  there  were  no  other  changes  in  relation  to
linical management,  acquisition  of  new  technologies,  or
lterations in  the  severity  proﬁle  of  cases  treated  in  this
nit, the  decrease  in  mortality  observed  may  be  related  to
 reduction  in  unnecessary  antimicrobial  use  as  a  result  of
mprovement in  the  diagnosis  of  probable  early-onset  sepsis,
he only  parameter  that  was  different  between  groups.
onclusionhis  study  demonstrated  that  the  implementation  of  the
rotocol suggested  by  ANVISA  decreased  the  number  of
iagnoses of  probable  early-onset  sepsis  and  the  need  for
ntimicrobial use  in  NBs  with  very  low  birth  weight.
10.89 11.61  0.075
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